Anthony Quinn, EVP, CMO, & Head of R&D at Synageva, holds 161.33K shares in Generation Bio (Ticker: GBIO), holds 816.84K shares in Spyre Therapeutics (Ticker: SYRE), holds 31.60K shares in Kaleido Biosciences (Ticker: KLDO). Most recently, Anthony Quinn Bought ― shares of Generation Bio on Dec 05, 2023 for an estimated value of 124.78K.